Fresenius SE & Co. KGaA (FRA:FRE)

Market Cap	27.54B
Revenue (ttm)	22.45B
Net Income (ttm)	1.14B
Shares Out	n/a
EPS (ttm)	2.03
PE Ratio	24.09
Forward PE	13.27
Dividend	1.00 (2.07%)
Ex-Dividend Date	May 26, 2025

Volume	714,584
Average Volume	1,210
Open	47.68
Previous Close	48.25
Day's Range	47.52 - 48.06
52-Week Range	32.00 - 50.72
Beta	n/a
RSI	46.87
Earnings Date	Nov 5, 2025

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly know...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1912
• Employees: 176,486
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FRE